Janus Henderson Group PLC Pacira Bio Sciences, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PCRX
# of Institutions
269Shares Held
51.3MCall Options Held
378KPut Options Held
1.43M-
Black Rock Inc. New York, NY8.01MShares$135 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$85.4 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$83.4 Million0.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$34.7 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$32 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $770M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...